AI Article Synopsis
- There is growing recognition and research on idiopathic intracranial hypertension (IIH), focusing on its underlying causes related to hormonal and metabolic imbalances.
- New consensus guidelines have been released to improve the investigation and treatment of adult IIH, incorporating updated criteria from the International Headache Society.
- Ongoing clinical trials and studies are being conducted to further explore IIH and develop effective therapies.
Article Abstract
There is increasing evidence and appreciation of idiopathic intracranial hypertension (IIH) in medicine. The pathological processes underlying raised intracranial pressure are being studied, with new insights found in both hormonal dysregulation and the metabolic neuroendocrine axis. These will potentially lead to novel therapeutic targets for IIH. The first consensus guidelines have been published on the investigation and management of adult IIH, and the International Headache Society criteria for headache attributable to IIH have been modified to reflect our evolving understanding of IIH. Randomized clinical trials have been published, and a number of studies in this disease area are ongoing.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708542 | PMC |
| http://dx.doi.org/10.1007/s40123-020-00296-0 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!